Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility Study of the Clinical and Cost-effectiveness of Contemporary Diagnostics for Patients With Suspected Hospital-Acquired Pneumonia (HAP).

NCT05483309 is registered in ClinicalTrials.gov with University of Liverpool as lead sponsor.

NCT NCT05483309
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05483309 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility Study of the Clinical and Cost-effectiveness of Contemporary Diagnostics for Patients With Suspected Hospital-Acquired Pneumonia (HAP).
Lead sponsor
University of Liverpool
Phase
Not applicable
Overall status
Completed
Start date
June 13, 2023
Completion date
June 11, 2025
Enrollment
220 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

hospital-acquired pneumonia